Advances in Corticosteroid Therapy for Ocular Inflammation: Loteprednol Etabonate

door Comstock, Timothy L., DeCory, Heleen H.
Gepubliceerd in 2012

Impact of the Topical Ophthalmic Corticosteroid Loteprednol Etabonate on Intraocular Pressure

door Sheppard, John D., Comstock, Timothy L., Cavet, Megan E.
Gepubliceerd in Adv Ther (2016)

Use of the Fluocinolone Acetonide Intravitreal Implant for the Treatment of Noninfectious Posterior Uveitis: 3-Year Results of a Randomized Clinical Trial in a Predominantly Asian...

door Sangwan, Virender S., Pearson, P. Andrew, Paul, Hemanth, Comstock, Timothy L.
Gepubliceerd in Ophthalmol Ther (2014)

An update on the surgical management of pterygium and the role of loteprednol etabonate ointment

door Sheppard, John D, Mansur, Arnulfo, Comstock, Timothy L, Hovanesian, John A
Gepubliceerd in 2014

Besifloxacin: a novel anti-infective for the treatment of bacterial conjunctivitis

door Comstock, Timothy L, Karpecki, Paul M, Morris, Timothy W, Zhang, Jin-Zhong
Gepubliceerd in 2010

Safety and efficacy of loteprednol etabonate ophthalmic ointment 0.5% for the treatment of inflammation and pain following cataract surgery

door Comstock, Timothy L, Paterno, Michael R, Singh, Angele, Erb, Tara, Davis, Elizabeth
Gepubliceerd in 2011

Post-cataract outcomes in patients with noninfectious posterior uveitis treated with the fluocinolone acetonide intravitreal implant

door Sheppard, John D, Nguyen, Quan Dong, Usner, Dale W, Comstock, Timothy L
Gepubliceerd in 2012

Concentrations of besifloxacin, gatifloxacin, and moxifloxacin in human conjunctiva after topical ocular administration

door Torkildsen, Gail, Proksch, Joel W, Shapiro, Aron, Lynch, Stephanie K, Comstock, Timothy L
Gepubliceerd in 2010

Besifloxacin ophthalmic suspension 0.6% in the treatment of bacterial conjunctivitis patients with Pseudomonas aeruginosa infections

door Silverstein, Bruce E, Morris, Timothy W, Gearinger, Lynne S, DeCory, Heleen H, Comstock, Timothy L
Gepubliceerd in 2012

Integrated analysis of three bacterial conjunctivitis trials of besifloxacin ophthalmic suspension, 0.6%: microbiological eradication outcomes

door Morris, Timothy W, Gearinger, Lynne S, Usner, Dale W, Paterno, Michael R, DeCory, Heleen H, Comstock, Timothy L, Haas, Wolfgang
Gepubliceerd in 2011

Antibacterial efficacy of prophylactic besifloxacin 0.6% and moxifloxacin 0.5% in patients undergoing cataract surgery

door Bucci, Frank A, Evans, Ruth E, Amico, Loretta M, Morris, Timothy W, Fluet, Angel T, Sanfilippo, Christine M, DeCory, Heleen H, Comstock, Timothy L
Gepubliceerd in Clin Ophthalmol (2015)